Oncology Diagnostics

Selected news for the healthcare topic - Oncology Diagnostics, collected since 10/2017. Recent stories appear in Globe Newswire and fool.com. This healthcare topic shares news with Biocept, Zacks Investment Research, Cancer Therapy, Genomics and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/16/2021 Immunoscore is now available in Rectal Cancer for expert Globe Newswire Immunoscore® is now available in Rectal Cancer for expert clinical centers through an Innovation Access Program May 11, 2021 08:00 ET HalioDx Marseille, FRANCE Immunoscore® heads up to become the standard precision tool for the “Watch and Wait” strategy in locally advanced rectal cancer Expert clinical centers already involved worldwide in this new Innovation Access Program Marseille, France, May 11, 2021 - HalioDx SAS, the immuno-oncology diagnostics ...
5/15/2021 Exact Sciences' First-Quarter Results Show Its Strength Under Pressure fool.com ... still able to post 10% year-over-year quarterly sales growth for Cologuard.IMAGE SOURCE: GETTY IMAGES.Precision oncology fell short It's unlikely that the $16.8 billion market-cap company's late 2019 purchase of oncology diagnostics player Genomic Health has been as fruitful as management hoped it would be. Exact Sciences' sales in precision oncology for the quarter came in at $129 million, a measly 1% increase from year-ago ...
5/15/2021 Exact Sciences' First-Quarter Results Show Its Strength Under Pressure newsbreak.com ... headwinds, the company was still able to post 10% year-over-year quarterly sales growth for Cologuard.Precision oncology fell short It's unlikely that the $16.8 billion market-cap company's late 2019 purchase of oncology diagnostics player Genomic Health has been as fruitful as management hoped it would be. Exact Sciences' sales in precision oncology for the quarter came in at $129 million, a measly 1% increase from year-ago ...
4/27/2021 Geneseeq and AstraZeneca Collaborate to Build Guangzhou Bio-Diagnostics Innovation Center PR Newswire TORONTO , April 27, 2021 /PRNewswire/ - Geneseeq Technology Inc. ("Geneseeq"), a precision oncology diagnostics company, and AstraZeneca (LSE: AZN) (STO: AZN) (Nasdaq: AZN ), a global biopharmaceutical company, are excited to announce their strategic collaboration to establish a Bio-Diagnostic Innovation Center in Guangzhou, China . The center is expected to initiate an integrative and patient-centric program where disease diagnosis, treatment, and rehabilitation coexist. The center will combine Geneseeq's expertise in developing ...